Structure Therapeutics Inc ADR (NASDAQ:GPCR) has a beta value of -4.96 and has seen 1.18 million shares traded in the last trading session. The company, currently valued at $1.69B, closed the last trade at $36.48 per share which meant it gained $1.68 on the day or 4.83% during that session. The GPCR stock price is -105.65% off its 52-week high price of $75.02 and 41.86% above the 52-week low of $21.21. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.91 million shares traded. The 3-month trading volume is 662.11K shares.
Structure Therapeutics Inc ADR (NASDAQ:GPCR) trade information
Sporting 4.83% in the green in last session, the stock has traded in the green over the last five days, when the GPCR stock price touched $36.48 or saw a rise of 1.3%. Year-to-date, Structure Therapeutics Inc ADR shares have moved -10.50%, while the 5-day performance has seen it change 3.37%. Over the past 30 days, the shares of Structure Therapeutics Inc ADR (NASDAQ:GPCR) have changed -20.35%. Short interest in the company has seen 3.04 million shares shorted with days to cover at 7.39.
Structure Therapeutics Inc ADR (GPCR) estimates and forecasts
Figures show that Structure Therapeutics Inc ADR shares have underperformed across the wider relevant industry. The company’s shares have gained 1.76% over the past 6 months, with this year growth rate of -17.28%, compared to 12.40% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 81.60% and 16.00% for the next quarter.
GPCR Dividends
Structure Therapeutics Inc ADR is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s Major holders
Insiders own 0.00% of the company shares, while shares held by institutions stand at 94.45% with a share float percentage of 94.45%. Investors are also buoyed by the number of investors in a company, with Structure Therapeutics Inc ADR having a total of 170 institutions that hold shares in the company. The top two institutional holders are Deep Track Capital, Lp with over 2.65 million shares worth more than $110.03 million. As of Jun 29, 2023, Deep Track Capital, Lp held 6.92% of shares outstanding.
The other major institutional holder is Price (T.Rowe) Associates Inc, with the holding of over 1.77 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $73.72 million and represent 4.63% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Price (T.Rowe) New Horizons Fund and Federated Hermes Kaufmann Fund. As of Jun 29, 2023, the former fund manager holds about 1.85% shares in the company for having 0.71 million shares of worth $29.5 million while later fund manager owns 0.5 million shares of worth $18.41 million as of Jul 30, 2023, which makes it owner of about 1.31% of company’s outstanding stock.
